IceCure Medical R&D Spending Growth & History (ICCM)
IceCure Medical's r&d spending was $7.4M for fiscal 2025.
View full IceCure Medical company overviewIceCure Medical annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.4M | $337,000 | +4.75% |
| 2024 | 2024-12-31 | $7.1M | −$1.2M | −14.23% |
| 2023 | 2023-12-31 | $8.3M | −$850,000 | −9.32% |
| 2022 | 2022-12-31 | $9.1M | $3.2M | +55.23% |
| 2021 | 2021-12-31 | $5.9M | $2.1M | +54.29% |
| 2020 | 2020-12-31 | $3.8M | $808,000 | +26.92% |
| 2019 | 2019-12-31 | $3.0M | — | — |
IceCure Medical quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.1M | $357,000 | +20.86% |
| Q1 2026 | 2026-03-31 | $2.2M | $547,000 | +32.87% |
| Q4 2025 | 2025-12-31 | $2.3M | — | — |
| Q3 2025 | 2025-09-30 | $1.8M | — | — |
| Q2 2025 | 2025-06-30 | $1.7M | — | — |
| Q1 2025 | 2025-03-31 | $1.7M | — | — |
IceCure Medical r&d spending trends
Over the last five fiscal years, IceCure Medical's r&d spending increased from $3.8M to $7.4M, a change of $3.6M. The latest reported quarter, Q2 2026, shows $2.1M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IceCure Medical source filings ↗